Health Decisions' Agile Clinical Development Network
The Agile Clinical Development Network is comprised of premium global partners that are united by central management and technology from Health Decisions' headquarters in North Carolina and vetted through stringent qualifications and values. As a result, the Agile Clinical Development Network combines data-driven management from the U.S. with regional experience and top leadership from proven partner CROs in each country or region.
All global partners in the Agile Clinical Development Network are certified in Health Decisions' HD360° Clinical Management System, a proprietary platform developed to provide full transparency of study metrics in real-time, regardless of location around the world. This network was developed to optimize and maximize the efficiency of global trials and alleviate the industry's struggles with complex, multinational programs. The Agile Clinical Development Network strives on Health Decisions' robust Clinical Management System enabling more efficient trial management, providing sponsors complete visibility into study progress at all times and minimizing the risk of failure regardless of location.
Working with our global network, Health Decisions achieves extraordinary synchronicity and unprecedented results.
Metastatic Breast Cancer
Number of Patients:
460, 95 sites
Countries:
Canada, Russia, UK, US
Outcome:
Trial completed one year ahead of expected; resulted in $366M in unplanned revenue to sponsor
Peripheral Arterial Occlusion
Number of Patients:
120, 36 sites
Countries:
Hungary, Russia, South Africa, UK, US
Outcome:
Big 5 pharma outlicensed because enrollment considered unfeasible; Enrolled faster than most optimistic projections
Alzheimer's
Number of Patients:
1500, 107 sites
Countries:
Australia, Canada, France, South Africa, UK, US
Outcome:
Saved $32M for the sponsor of $110M study by cutting 1.5 years off 5-year timeline